Coughlin Steven S
Am J Epidemiol. 2017 Aug 15;186(4):393-394. doi: 10.1093/aje/kwx065.
Measures for ensuring that epidemiologic studies are reproducible include making data sets and software available to other researchers so they can verify published findings, conduct alternative analyses of the data, and check for statistical errors or programming errors. Recent developments related to the reproducibility and transparency of epidemiologic studies include the creation of a global platform for sharing data from clinical trials and the anticipated future extension of the global platform to non-clinical trial data. Government agencies and departments such as the US Department of Veterans Affairs Cooperative Studies Program have also enhanced their data repositories and data sharing resources. The Institute of Medicine and the International Committee of Medical Journal Editors released guidance on sharing clinical trial data. The US National Institutes of Health has updated their data-sharing policies. In this issue of the Journal, Shepherd et al. (Am J Epidemiol. 2017;186:387-392) outline a pragmatic approach for reproducible research with sensitive data for studies for which data cannot be shared because of legal or ethical restrictions. Their proposed quasi-reproducible approach facilitates the dissemination of statistical methods and codes to independent researchers. Both reproducibility and quasi-reproducibility can increase transparency for critical evaluation, further dissemination of study methods, and expedite the exchange of ideas among researchers.
确保流行病学研究具有可重复性的措施包括向其他研究人员提供数据集和软件,以便他们能够验证已发表的研究结果、对数据进行替代分析,并检查统计错误或编程错误。与流行病学研究的可重复性和透明度相关的最新进展包括创建一个用于共享临床试验数据的全球平台,以及预计该全球平台未来将扩展到非临床试验数据。美国退伍军人事务部合作研究计划等政府机构和部门也加强了其数据存储库和数据共享资源。医学研究所和医学期刊编辑国际委员会发布了关于共享临床试验数据的指南。美国国立卫生研究院更新了其数据共享政策。在本期《期刊》中,谢泼德等人(《美国流行病学杂志》。2017年;186:387 - 392)概述了一种实用的方法,用于对因法律或伦理限制而无法共享数据的研究进行具有敏感数据的可重复性研究。他们提出的准可重复性方法有助于向独立研究人员传播统计方法和代码。可重复性和准可重复性都可以提高关键评估的透明度、进一步传播研究方法,并加快研究人员之间的思想交流。